Antisense Therapeutics Limited
Antisense Therapeutics Limited (ATHJF) Revenue
Annual & quarterly revenue history · segment & region breakdown
ATHJF · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsAntisense Therapeutics Limited trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Antisense Therapeutics Limited receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Antisense Therapeutics Limited reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Antisense Therapeutics Limited's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
ATHJF revenue · 4 questionsATHJF's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · Antisense Therapeutics Limited SEC filings · GAAP · Antisense Therapeutics Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026